Skip to main content
Clinical Trials/NCT05553119
NCT05553119
Completed
N/A

Home-based Pulmonary Rehabilitation and Health Coaching in Bronchiectasis

Mayo Clinic1 site in 1 country35 target enrollmentAugust 25, 2022
ConditionsBronchiectasis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bronchiectasis
Sponsor
Mayo Clinic
Enrollment
35
Locations
1
Primary Endpoint
Change in patient-reported quality of life
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to gather information on the effectiveness on a home-based pulmonary rehabilitation in patients with bronchiectasis.

Detailed Description

The purpose of this study is to gather information on the effectiveness on a home-based pulmonary rehabilitation in patients with bronchiectasis. We hope that by participating in home-rehab that patients with bronchiectasis will become more physically active in their daily lives. Pulmonary Rehabilitation in a medical center has proven to have a positive impact on physical activity and shortness of breath in patients with chronic lung disease. However, travel and access can make going to a center difficult. Study participation involves completing gentle flexibility exercises and walking practice using a provided computer tablet, pulse oximeter and an activity tracker for 12 weeks. During that time, you will talk to a health coach once a week on the phone. At the end of the 12 weeks, someone will call you and ask you questions about your experience with the home-based rehab. Health Coaching calls will be recorded so that it can later be transcribed. All identifying information will be removed and the answers will be lumped together.

Registry
clinicaltrials.gov
Start Date
August 25, 2022
End Date
July 30, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Roberto P. Benzo

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Having a diagnosis of non-cystic fibrosis bronchiectasis (primary inclusion criteria) ,confirmed by records, that are symptomatic.
  • Ability to communicate in English.

Exclusion Criteria

  • Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility).
  • Cognitive impairment or inability to understand and follow instructions.
  • Traditional PR completed within 3 months of study recruitment.
  • Hospice or end-of-life care at the time of screening.
  • Acute exacerbation at the time of screening.

Outcomes

Primary Outcomes

Change in patient-reported quality of life

Time Frame: Baseline, after completion of the 12-week intervention.

As defined by the COPD Assessment Test (CAT). The CAT is a validated tool for measuring health status in patients with bronchiectasis and is divided into eight domains of cough, mucous production, chest tightness, shortness of breath with activity, activity limitation at home, confidence leaving home, sleep quality, and energy. A lower score suggests no health-related quality of life (HRQL) impairment, while the maximum score of 40 represents significant impact.

Secondary Outcomes

  • Physical activity(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials